156 related articles for article (PubMed ID: 29544432)
1. Studies of the Process of Amyloid Formation by Aβ Peptide.
Galzitskaya OV; Galushko EI; Selivanova OM
Biochemistry (Mosc); 2018 Jan; 83(Suppl 1):S62-S80. PubMed ID: 29544432
[TBL] [Abstract][Full Text] [Related]
2. To Be Fibrils or To Be Nanofilms? Oligomers Are Building Blocks for Fibril and Nanofilm Formation of Fragments of Aβ Peptide.
Selivanova OM; Surin AK; Ryzhykau YL; Glyakina AV; Suvorina MY; Kuklin AI; Rogachevsky VV; Galzitskaya OV
Langmuir; 2018 Feb; 34(6):2332-2343. PubMed ID: 29338255
[TBL] [Abstract][Full Text] [Related]
3. Rosetta Stone for Amyloid Fibrils: The Key Role of Ring-Like Oligomers in Amyloidogenesis.
Galzitskaya OV; Selivanova OM
J Alzheimers Dis; 2017; 59(3):785-795. PubMed ID: 28671122
[TBL] [Abstract][Full Text] [Related]
4. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
5. Structural model of amyloid fibrils for amyloidogenic peptide from Bgl2p-glucantransferase of S. cerevisiae cell wall and its modifying analog. New morphology of amyloid fibrils.
Selivanova OM; Glyakina AV; Gorbunova EY; Mustaeva LG; Suvorina MY; Grigorashvili EI; Nikulin AD; Dovidchenko NV; Rekstina VV; Kalebina TS; Surin AK; Galzitskaya OV
Biochim Biophys Acta; 2016 Nov; 1864(11):1489-99. PubMed ID: 27500912
[TBL] [Abstract][Full Text] [Related]
6. One of the possible mechanisms of amyloid fibrils formation based on the sizes of primary and secondary folding nuclei of Aβ40 and Aβ42.
Dovidchenko NV; Glyakina AV; Selivanova OM; Grigorashvili EI; Suvorina MY; Dzhus UF; Mikhailina AO; Shiliaev NG; Marchenkov VV; Surin AK; Galzitskaya OV
J Struct Biol; 2016 Jun; 194(3):404-14. PubMed ID: 27016282
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
Singh PK; Maji SK
Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
[TBL] [Abstract][Full Text] [Related]
8. Study on the inter- and intra-peptide salt-bridge mechanism of Aβ23-28 oligomer interaction with small molecules: QM/MM method.
Boopathi S; Kolandaivel P
Mol Biosyst; 2015 Jul; 11(7):2031-41. PubMed ID: 25973904
[TBL] [Abstract][Full Text] [Related]
9. The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-β Peptide.
Selivanova OM; Surin AK; Marchenkov VV; Dzhus UF; Grigorashvili EI; Suvorina MY; Glyakina AV; Dovidchenko NV; Galzitskaya OV
J Alzheimers Dis; 2016 Sep; 54(2):821-30. PubMed ID: 27567850
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.
Di Scala C; Chahinian H; Yahi N; Garmy N; Fantini J
Biochemistry; 2014 Jul; 53(28):4489-502. PubMed ID: 25000142
[TBL] [Abstract][Full Text] [Related]
11. Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments.
Galzitskaya OV; Surin AK; Glyakina AV; Rogachevsky VV; Selivanova OM
J Alzheimers Dis Rep; 2018 Oct; 2(1):181-199. PubMed ID: 30480261
[TBL] [Abstract][Full Text] [Related]
12. Peptide backbone modification in the bend region of amyloid-β inhibits fibrillogenesis but not oligomer formation.
Johnson EC; Lanning JD; Meredith SC
J Pept Sci; 2016 May; 22(5):368-73. PubMed ID: 27114096
[TBL] [Abstract][Full Text] [Related]
13. Exogenous amyloidogenic proteins function as seeds in amyloid β-protein aggregation.
Ono K; Takahashi R; Ikeda T; Mizuguchi M; Hamaguchi T; Yamada M
Biochim Biophys Acta; 2014 Apr; 1842(4):646-53. PubMed ID: 24440525
[TBL] [Abstract][Full Text] [Related]
14. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
15. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
[TBL] [Abstract][Full Text] [Related]
16. Structural Characterization of Amyloid β17-42 Dimer by Potential of Mean Force Analysis: Insights from Molecular Dynamics Simulations.
Dutta M; Chutia R; Mattaparthi VSK
Protein Pept Lett; 2017; 24(7):650-660. PubMed ID: 28641562
[TBL] [Abstract][Full Text] [Related]
17. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
[TBL] [Abstract][Full Text] [Related]
18. Aromaticity of Phenylalanine Residues Is Essential for Amyloid Formation by Alzheimer's Amyloid β-Peptide.
Genji M; Yano Y; Hoshino M; Matsuzaki K
Chem Pharm Bull (Tokyo); 2017; 65(7):668-673. PubMed ID: 28674340
[TBL] [Abstract][Full Text] [Related]
19. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer.
Robb E; Perez K; Hung LW; Masters CL; Barnham KJ; Cherny RA; Bush AI; Adlard PA; Finkelstein DI
J Alzheimers Dis; 2015; 44(1):69-78. PubMed ID: 25182735
[TBL] [Abstract][Full Text] [Related]
20. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
Poduslo JF; Howell KG
J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
